We are live on
!
Find out more
AC
Argentiere Capital Portfolio holdings
AUM
$15.4M
1-Year Est. Return
8.82%
This Fund
S&P 500
This Quarter
Est. Return
-0.02%
1 Year Est. Return
-8.82%
3 Year Est. Return
+1.98%
5 Year Est. Return
+9.17%
10 Year Est. Return
–
AUM
$15.4M
AUM Growth
-$215M
(-93%)
Cap. Flow
-$215M
Cap. Flow
% of AUM
-1,396.57%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
39
New
–
Increased
–
Reduced
1
Closed
37
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$7.55M |
| 2 |
RHT
Red Hat Inc
RHT
|
+$5.54M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$4.42M |
| 4 |
AGN
Allergan plc
AGN
|
+$3.81M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$3.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 0% |
| 2 | Energy | 0% |
| 3 | Financials | 0% |
| 4 | Healthcare | 0% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RHT
1
PUT
DELISTED
Red Hat Inc
RHT
| $14.1M | 91.39% |
75,000
-35,000
| -32% | -$6.46M |
|
2
iShares MSCI Emerging Markets ETF
EEM
$28.8B
| $1.33M | 8.61% |
30,900
| – | – |
|
3
Apple
AAPL
$4.54T
| – | – |
-73,192
| Closed | -$3.48M |
|
|
4
BioMarin Pharmaceuticals
BMRN
$11.6B
| – | – |
-42,000
| Closed | -$3.73M |
|
5
CALL
Bristol-Myers Squibb
BMY
$133B
| – | – |
-262,000
| Closed | -$12.5M |
|
6
CALL
Capital One
COF
$128B
| – | – |
-50,000
| Closed | -$4.08M |
|
|
7
PUT
Capital One
COF
$128B
| – | – |
-50,000
| Closed | -$4.08M |
|
8
CALL
CSX Corp
CSX
$93.4B
| – | – |
-150,000
| Closed | -$3.74M |
|
|
9
PUT
CSX Corp
CSX
$93.4B
| – | – |
-150,000
| Closed | -$3.74M |
|
10
CALL
Chevron
CVX
$392B
| – | – |
-50,000
| Closed | -$6.16M |
|
|
11
PUT
Chevron
CVX
$392B
| – | – |
-50,000
| Closed | -$6.16M |
|
12
iShares China Large-Cap ETF
FXI
$4.37B
| – | – |
-38,988
| Closed | -$1.73M |
|
13
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| – | – |
-200,000
| Closed | -$17.3M |
|
14
CALL
Eli Lilly
LLY
$1.02T
| – | – |
-45,000
| Closed | -$5.84M |
|
|
15
PUT
Eli Lilly
LLY
$1.02T
| – | – |
-50,000
| Closed | -$6.49M |
|
16
Southwest Airlines
LUV
$22B
| – | – |
-17,517
| Closed | -$909K |
|
17
CALL
MetLife
MET
$61.9B
| – | – |
-50,000
| Closed | -$2.13M |
|
|
18
MetLife
MET
$61.9B
| – | – |
-18,135
| Closed | -$772K |
|
|
19
PUT
MetLife
MET
$61.9B
| – | – |
-50,000
| Closed | -$2.13M |
|
20
CALL
Merck
MRK
$322B
| – | – |
-52,400
| Closed | -$4.16M |
|
|
21
PUT
Merck
MRK
$322B
| – | – |
-52,400
| Closed | -$4.16M |
|
22
CALL
Morgan Stanley
MS
$331B
| – | – |
-100,000
| Closed | -$4.22M |
|
|
23
PUT
Morgan Stanley
MS
$331B
| – | – |
-50,000
| Closed | -$2.11M |
|
24
CALL
Norfolk Southern
NSC
$75.4B
| – | – |
-30,000
| Closed | -$5.61M |
|
|
25
PUT
Norfolk Southern
NSC
$75.4B
| – | – |
-30,000
| Closed | -$5.61M |
|
Similar funds
TCM
HCA
DPA
MP
MMPI
AF
KAM
BA
Argentiere Capital's Q2 2019 Portfolio in Review
As of Q2 2019, Argentiere Capital held 39 positions worth $15.4M, down 93% from $230M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Argentiere Capital withdrew a net $215M in Q2 2019, closing 37 positions and reducing 1 holding. Its most notable exit was Celgene Corp, an estimated $7.55M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 0% of assets, down from 2.4% a quarter earlier, followed by Energy and Financials.
- Argentiere Capital fully exited Celgene Corp in Q2 2019, selling an estimated $7.55M.
- Argentiere Capital's ten largest holdings make up 100% of its $15.4M portfolio in Q2 2019.
- Argentiere Capital opened 0 new positions and closed 37 in Q2 2019.
- Argentiere Capital's portfolio value fell 93% quarter-over-quarter to $15.4M.
Based on Argentiere Capital's 13F filing for Q2 2019, filed 14 Aug 2019.